NOVASAID AB has a total of 17 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and computer technology are PFIZER INC A CORP ORGANIZED UN, NEREUS PHARMACEUTICALS INC and PFIZER RES AND DEV CO NV SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 4 | |
#4 | Canada | 2 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Computer technology | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Bioinformatics | |
#6 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Wannberg Johan | 10 |
#2 | Stenberg Patric | 8 |
#3 | Alterman Mathias | 6 |
#4 | Westman Jacob | 5 |
#5 | Morgenstern Ralf | 3 |
#6 | Malm Johan | 3 |
#7 | Hebert Hans | 3 |
#8 | Jakobsson Per-Johan | 3 |
#9 | Jegerschoeld Caroline | 2 |
#10 | Jegerschold Caroline | 1 |
Publication | Filing date | Title |
---|---|---|
CN105658645A | Piperidinyl benzoimidazole derivatives as MPGE-1 inhibitors | |
EP2495244A1 | Piperidinyl benzoimidazole derivatives as mPGEs-1 inhibitors | |
WO2011023812A1 | Microsomal prostaglandin e synthase-1 (mpges1) inhibitors | |
WO2009130242A1 | Low molecular weight derivatives and use thereof in treatment of prostaglandin e synthase related diseases | |
WO2009103778A1 | Compounds and methods | |
WO2009098282A1 | Low molecular weight 2,5-disubstituted thiophene derivatives and use thereof in therapy | |
US2011207113A1 | Protein structure and method of using protein structure |